Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRE-D Trial of dapagliflozin, metformin, and physical activity in prediabetes
2015-001552-30Phase 2Completed
- Sponsor
- Steno Diabetes Center
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dapagliflozin and metformin in prediabetes (3 arms), sponsored by Steno Diabetes Center. Primary endpoint: Reduction in mean amplitude of glycaemic excursions. Started Aug 2015; status: completed.
02
Drugs
dapagliflozinmetformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2015-001552-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001552-30.